These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
331 related articles for article (PubMed ID: 22171585)
1. Pharmacokinetics, drug interactions and exposure-response relationship of eslicarbazepine acetate in adult patients with partial-onset seizures: population pharmacokinetic and pharmacokinetic/pharmacodynamic analyses. Falcão A; Fuseau E; Nunes T; Almeida L; Soares-da-Silva P CNS Drugs; 2012 Jan; 26(1):79-91. PubMed ID: 22171585 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of eslicarbazepine acetate at steady-state in adults with partial-onset seizures. Perucca E; Elger C; Halász P; Falcão A; Almeida L; Soares-da-Silva P Epilepsy Res; 2011 Sep; 96(1-2):132-9. PubMed ID: 21680153 [TBL] [Abstract][Full Text] [Related]
3. Concentration-effect relationships with perampanel in patients with pharmacoresistant partial-onset seizures. Gidal BE; Ferry J; Majid O; Hussein Z Epilepsia; 2013 Aug; 54(8):1490-7. PubMed ID: 23772853 [TBL] [Abstract][Full Text] [Related]
4. Population Pharmacokinetics and Exposure-Response Analyses of Eslicarbazepine Acetate Efficacy and Safety in Monotherapy of Partial-Onset Seizures. Sunkaraneni S; Ludwig EA; Passarell JA; Blum D; Grinnell T; Fiedler-Kelly J J Clin Pharmacol; 2018 Jul; 58(7):927-938. PubMed ID: 29528499 [TBL] [Abstract][Full Text] [Related]
5. Modeling and simulations to support dose selection for eslicarbazepine acetate therapy in pediatric patients with partial-onset seizures. Sunkaraneni S; Ludwig E; Fiedler-Kelly J; Hopkins S; Galluppi G; Blum D J Pharmacokinet Pharmacodyn; 2018 Aug; 45(4):649-658. PubMed ID: 29948795 [TBL] [Abstract][Full Text] [Related]
6. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy. Perucca E; Cloyd J; Critchley D; Fuseau E Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564 [TBL] [Abstract][Full Text] [Related]
7. Exposure-safety and efficacy response relationships and population pharmacokinetics of eslicarbazepine acetate. Gidal BE; Jacobson MP; Ben-Menachem E; Carreño M; Blum D; Soares-da-Silva P; Falcão A; Rocha F; Moreira J; Grinnell T; Ludwig E; Fiedler-Kelly J; Passarell J; Sunkaraneni S Acta Neurol Scand; 2018 Sep; 138(3):203-211. PubMed ID: 29732549 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and drug interactions of eslicarbazepine acetate. Bialer M; Soares-da-Silva P Epilepsia; 2012 Jun; 53(6):935-46. PubMed ID: 22612290 [TBL] [Abstract][Full Text] [Related]
9. Tolerability of adjunctive eslicarbazepine acetate according to concomitant lamotrigine or carbamazepine use: A subgroup analysis of three phase III trials in adults with focal (partial-onset) seizures. Abou-Khalil B; Klein P; Shah A; Ryvlin P; Specchio LM; Gama H; Rocha F; Blum D; Grinnell T; Cheng H; Jung J Epilepsy Res; 2018 Nov; 147():80-86. PubMed ID: 30278294 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: a randomized, double-blind, placebo-controlled, parallel-group phase III study. Elger C; Halász P; Maia J; Almeida L; Soares-da-Silva P; Epilepsia; 2009 Mar; 50(3):454-63. PubMed ID: 19243424 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic/pharmacodynamic analysis of adjunctive perampanel in subjects with partial-onset seizures. Takenaka O; Ferry J; Saeki K; Laurenza A Acta Neurol Scand; 2018 Apr; 137(4):400-408. PubMed ID: 29171002 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic interaction study between eslicarbazepine acetate and topiramate in healthy subjects. Nunes T; Sicard E; Almeida L; Falcão A; Rocha JF; Brunet JS; Lefebvre M; Soares-da-Silva P Curr Med Res Opin; 2010 Jun; 26(6):1355-62. PubMed ID: 20377319 [TBL] [Abstract][Full Text] [Related]
13. Topiramate therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs. Contin M; Riva R; Albani F; Avoni P; Baruzzi A Ther Drug Monit; 2002 Jun; 24(3):332-7. PubMed ID: 12021622 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and safety of adjunctive topiramate in infants (1-24 months) with refractory partial-onset seizures: a randomized, multicenter, open-label phase 1 study. Manitpisitkul P; Shalayda K; Todd M; Wang SS; Ness S; Ford L Epilepsia; 2013 Jan; 54(1):156-64. PubMed ID: 23157581 [TBL] [Abstract][Full Text] [Related]
15. A pooled analysis of lacosamide clinical trial data grouped by mechanism of action of concomitant antiepileptic drugs. Sake JK; Hebert D; Isojärvi J; Doty P; De Backer M; Davies K; Eggert-Formella A; Zackheim J CNS Drugs; 2010 Dec; 24(12):1055-68. PubMed ID: 21090839 [TBL] [Abstract][Full Text] [Related]
16. Eslicarbazepine Acetate Monotherapy: A Review in Partial-Onset Seizures. Shirley M; Dhillon S Drugs; 2016 Apr; 76(6):707-17. PubMed ID: 27055527 [TBL] [Abstract][Full Text] [Related]
17. Eslicarbazepine acetate: an update on efficacy and safety in epilepsy. Verrotti A; Loiacono G; Rossi A; Zaccara G Epilepsy Res; 2014 Jan; 108(1):1-10. PubMed ID: 24225327 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic interaction of brivaracetam on other antiepileptic drugs in adults with focal seizures: Pooled analysis of data from randomized clinical trials. Moseley BD; Otoul C; Staelens L; Stockis A Epilepsy Res; 2019 Dec; 158():106218. PubMed ID: 31675621 [TBL] [Abstract][Full Text] [Related]
19. Effects of antiepileptic comedication on levetiracetam pharmacokinetics: a pooled analysis of data from randomized adjunctive therapy trials. Perucca E; Gidal BE; Baltès E Epilepsy Res; 2003 Feb; 53(1-2):47-56. PubMed ID: 12576167 [TBL] [Abstract][Full Text] [Related]
20. Eslicarbazepine acetate: its effectiveness as adjunctive therapy in clinical trials and open studies. Shorvon SD; Trinka E; Steinhoff BJ; Holtkamp M; Villanueva V; Peltola J; Ben-Menachem E J Neurol; 2017 Mar; 264(3):421-431. PubMed ID: 28101651 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]